Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Cubist Pharmaceuticals LLC
ClinicalTrials.gov Identifier:
NCT00135577
First received: August 24, 2005
Last updated: September 1, 2015
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2007
  Primary Completion Date: April 2007 (Final data collection date for primary outcome measure)